Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;13(6):1373-1381.
doi: 10.1111/eip.12774. Epub 2019 Jan 28.

Aripiprazole compared with placebo for auditory verbal hallucinations in youth with borderline personality disorder: Protocol for the VERBATIM randomized controlled trial

Andrew M Chanen  1   2   3 , Jennifer Betts  1   2 , Henry Jackson  4 , Patrick McGorry  1   2 , Barnaby Nelson  1   2 , Sue M Cotton  1   2 , Cali Bartholomeusz  1   2 , Martina Jovev  1   2   3 , Aswin Ratheesh  1   2   3 , Christopher Davey  1   2   3 , Christos Pantelis  5 , Louise McCutcheon  1   3 , Shona Francey  1   2   3 , Amit Bhaduri  1   2   3 , Danielle Lowe  1   2 , Victoria Rayner  1   2 , Katherine Thompson  1   2
Affiliations

Aripiprazole compared with placebo for auditory verbal hallucinations in youth with borderline personality disorder: Protocol for the VERBATIM randomized controlled trial

Andrew M Chanen et al. Early Interv Psychiatry. 2019 Dec.

Abstract

Aim: Up to half of patients with borderline personality disorder report auditory verbal hallucinations that are phenomenologically indistinguishable from those in schizophrenia, occur early in the course of the disorder, and are enduring, distressing and disabling. In clinical practice, this symptom is widely assumed to be unresponsive to treatment with antipsychotic medication and early intervention is rarely offered. The Verbal Experiences Response in Borderline personality disorder to Aripiprazole TrIal Medication (VERBATIM) study aims to be the first controlled trial to investigate the effectiveness of conventional pharmacotherapy for this symptom in this patient group.

Method: VERBATIM is a 12-week, triple-blind, single-centre, parallel groups randomised controlled trial, with a 27-week follow-up period. Participants between the ages of 15 and 25 years receive either aripiprazole or placebo daily, commencing at 2 mg and increasing to 10 mg by day 15. Further dose escalations (up to 30 mg) may occur, as clinically indicated. This trial was prospectively registered with the Australian and New Zealand Clinical Trials Registry ACTRN12616001192471 on 30/08/2016.

Results: The primary outcome is severity of auditory verbal hallucinations assessed using the Psychotic Symptom Rating Scale. Secondary outcomes include the severity of general psychopathology, borderline personality pathology, social and occupational functioning and change in brain resting state connectivity. The primary endpoint is week 12 and secondary endpoint is week 39.

Conclusion: The results will inform treatment decisions for individuals with borderline personality disorder who present with auditory verbal hallucinations.

Keywords: aripiprazole; borderline personality disorder; controlled trial; hallucinations; psychosis.

PubMed Disclaimer

References

REFERENCES

    1. Adams, B., & Sanders, T. (2011). Experiences of psychosis in borderline personality disorder: A qualitative analysis. Journal of Mental Health, 20, 381-391.
    1. Allott, K., Chanen, A., & Yuen, H. P. (2006). Attrition bias in longitudinal research involving adolescent psychiatric outpatients. The Journal of Nervous and Mental Disease, 194, 958-961.
    1. American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd ed.). Washington, DC: American Psychiatric Publishing.
    1. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
    1. Antony, M. M., Bieling, P. J., Cox, B. J., Enns, M. W., & Swinson, R. P. (1998). Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychological Assessment, 10, 176.

Publication types

LinkOut - more resources